← Find a medication
Other Specialties

Korsuva

Generic: difelikefalin

Manufacturer: Vifor Pharma  ·  Program:

Apply for assistance

Free to apply. Service from $40/month, payable only when your application is ready to submit.

Eligibility Criteria

Insurance Requirement

See program details

Residency

US residency required

Program Information

Processing Time

2–4 weeks

Delivery Method

Varies by program

Application Method

Online

Indicated for

moderate-to-severe pruritus associated with chronic kidney disease in adults undergoing hemodialysis

About This Medication

Vifor Pharma Patient Assistance Program Guide: How to Get Korsuva (difelikefalin) at Low or No Cost

Korsuva (difelikefalin) is a prescription injection used to relieve moderate-to-severe itching (pruritus) linked to chronic kidney disease in adults on hemodialysis. This guide explains how to access Vifor Pharma's patient assistance program (PAP) for free or low-cost Korsuva if you qualify, helping ease the burden of this distressing symptom.[1][3]

About Korsuva and CKD-Associated Pruritus

Chronic kidney disease-associated pruritus (CKD-aP) affects up to 60-90% of adults on hemodialysis, causing intense, widespread itching that disrupts sleep, mood, and quality of life. Unlike typical itches, CKD-aP stems from kidney disease and dialysis, often resisting standard treatments like creams or antihistamines.[1][3]

Korsuva is the first FDA-approved therapy specifically for moderate-to-severe CKD-aP in hemodialysis patients. Administered intravenously by your dialysis center during sessions, it targets kappa opioid receptors in the brain and spinal cord to reduce itch signals without the risks of traditional opioids like addiction or heavy sedation. It's not recommended for peritoneal dialysis patients.[1][3][9]

Key benefits from clinical trials (KALM-1 and KALM-2):

  • Up to 50% reduction in itch severity.
  • Improved sleep and quality of life.
  • Common side effects: dizziness, diarrhea, nausea (usually mild).[1][9]

Always discuss with your doctor; report side effects to Vifor at 1-844-735-9772 or FDA at 1-800-FDA-1088.[1][5]

Who Qualifies for Vifor Pharma's Patient Assistance Program?

Vifor Pharma (manufacturer of Korsuva) offers a patient assistance program providing free medication to those who can't afford it due to financial hardship. While exact details like income limits aren't publicly listed online, typical PAPs target uninsured, underinsured, or low-income patients—often at or below 400% of the Federal Poverty Level (FPL).[2]

General eligibility criteria (based on standard Vifor programs like VeltassaKonnect):

  • U.S. resident with valid prescription for Korsuva.
  • Household income below program thresholds.
  • Lack of sufficient insurance coverage.
  • Not enrolled in government programs that fully cover (details below).[2]

Contact Vifor for personalized eligibility: 1-844-735-9772 or Medinfo_US@viforpharma.com.[1][5]

Income Eligibility Breakdown

Specific Korsuva PAP income thresholds aren't detailed in available sources, but Vifor programs generally follow FPL guidelines. Here's a sample table based on common PAP structures (2026 FPL estimates; confirm with Vifor as they update annually):

Household Size400% FPL Example (Annual Income)Notes
1 (Individual)~$60,000Typical max for free meds
2 (Couple)~$81,000Add ~$21,000 per extra person
3~$102,000Excludes high medical expenses in some cases
4~$123,000Vifor may adjust for dialysis costs

Table is illustrative; call 1-844-735-9772 for exact Korsuva thresholds and proof like tax returns required.[2]

Insurance Requirements

Vifor PAPs often require exhausting insurance options first. Key points:

  • Medicare Part D: May cover Korsuva under TDAPA (Transitional Drug Add-on Payment Adjustment) for ESRD drugs, but high copays/deductibles common. PAP bridges gaps.[8]
  • Commercial insurance: Submit denial or high cost-sharing proof.
  • Uninsured: Primary candidates.
  • Medicaid/VA: Usually ineligible.

Your dialysis center may bill under ESRD PPS bundle post-TDAPA (ends ~2024); PAP helps if uncovered.[7][8]

Step-by-Step Application Process

  1. Get Prescribed: Ask your nephrologist for Korsuva if CKD-aP persists.
  2. Contact Vifor: Call 1-844-735-9772 or email Medinfo_US@viforpharma.com to start. Mention Korsuva PAP.[1][5]
  3. Gather Documents: Typically includes:
    • Prescription.
    • Proof of income (tax return, pay stubs, SSI letter).
    • Insurance denial (if applicable).
    • ID and dialysis proof.[2]
  4. Submit Application: Doctor completes e-application or mails to Vifor. Digital portals common.
  5. Approval Wait: See FAQ for timeline.
  6. Receive Meds: Shipped to dialysis center for IV administration.[2]

Your dialysis team handles most logistics since Korsuva is given during sessions.

Timeline and Delivery

Processing: 2-4 weeks typical for PAPs; expedited for urgent cases. Once approved, supply lasts 12 months or per policy. Delivery: Direct to authorized dialysis clinics—no home shipment needed. Refills require reauthorization.[2]

Alternatives if Denied or Ineligible

  • VeltassaKonnect: Vifor's copay assistance for insured patients (sister program).[2]
  • NeedyMeds/RxAssist: Search general CKD itch PAPs.
  • Manufacturer Samples: Ask doctor for bridge supply.
  • Clinical Trials: Check ClinicalTrials.gov for Korsuva studies.
  • Generic/Off-label: No generics; alternatives like gabapentin (off-label, less effective).[1][2]

Appeal denials with updated finances or doctor letter.

Important Disclaimer

This guide is for informational purposes only and based on publicly available data as of 2026. Program details change—always verify with Vifor at 1-844-735-9772. Not medical advice; consult your doctor. Vifor not liable for application errors. Income tables illustrative; actual eligibility per Vifor policy.[1][2][5]

Program information last verified: March 30, 2026

Ready to apply for Korsuva assistance?

ProvisionRX manages the complete application process. Start your application in about 15 minutes.

Start My ApplicationBrowse All Medications

Need help finding a program?